Target Name: MIR6764
NCBI ID: G102466730
Other Name(s): hsa-miR-6764-5p | hsa-miR-6764-3p | microRNA 6764 | hsa-mir-6764 | MicroRNA 6764

MIR6764: A Potential Drug Target and Biomarker

MIR6764 (hsa-miR-6764-5p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study and develop new treatments.

MIR6764 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in gene expression. It is expressed in various tissues and cells throughout the body and has been shown to participate in various biological processes, including cell growth, apoptosis, and inflammation.

One of the reasons why MIR6764 has gained significant attention is its expression pattern. It is highly expressed in various tissues, including the brain, heart, and liver, and has been shown to be involved in the development and progression of various diseases, including cancer.

MIR6764 has also been shown to play a role in cell apoptosis, which is the process by which cells die naturally when they have reached their maximum number of copies or when they are no longer needed. Studies have shown that MIR6764 is involved in the regulation of cell apoptosis and that it can have a negative impact on cell survival.

In addition to its role in cell apoptosis, MIR6764 has also been shown to be involved in the regulation of cell growth. Studies have shown that MIR6764 can inhibit the growth of cancer cells and that it has a negative impact on the survival of cancer cells.

MIR6764 has also been shown to be involved in the regulation of inflammation. Studies have shown that MIR6764 can modulate the expression of immune cells and that it can have a negative impact on the production of pro-inflammatory cytokines.

Despite its potential as a drug target and biomarker, MIR6764 has not yet been studied in depth. There are currently no drugs that are specifically designed to target MIR6764, and research is still in the early stages of exploring its potential as a drug and biomarker.

However, studies have shown that MIR6764 can be a promising drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to study and develop new treatments.

In conclusion, MIR6764 is a non-coding RNA molecule that has gained significant attention due to its unique structure and expression pattern. Further research is needed to fully understand its potential as a drug target and biomarker for various diseases, including cancer.

Protein Name: MicroRNA 6764

More Common Targets

MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814 | MIR6815 | MIR6816 | MIR6817 | MIR6818 | MIR6819 | MIR6820 | MIR6821 | MIR6822 | MIR6823 | MIR6824 | MIR6825 | MIR6826 | MIR6827 | MIR6828 | MIR6829 | MIR6830 | MIR6831 | MIR6832 | MIR6833 | MIR6834 | MIR6836 | MIR6837 | MIR6839 | MIR6840 | MIR6841 | MIR6842 | MIR6843 | MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4